Recommended Resources – An Interview with Paul Leinwand and Cesare Mainardi, authors of The Essential Advantage
Strategy Driven
MARCH 18, 2011
In 2006, Pfizer directly redeemed the value built by PCH by selling the business to Johnson & Johnson for an unprecedented US$16.6 times EBITDA (compared to average multiples of 15 at the time). In 2006, Pfizer directly redeemed the value built by PCH by selling the business to Johnson & Johnson for an unprecedented US$16.6
51 
Let's personalize your content